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cost is c. 30 euros ⁄ test, and this can be reduced
further if the test is performed routinely. High
plasma concentrations of b-lactams have neuro-
logical toxicity [7]. The mental status of patients
receiving high doses of b-lactams has not been
investigated thoroughly, and the effects of the
very high b-lactam concentrations observed in the
present study could be insidious and remain
unsuspected. For example, lethargy, asthenia,
depression and anorexia are common symptoms
in elderly patients treated for endocarditis and are
investigated rarely.
The main caveat for the systematic monitor-
ing of b-lactam concentrations during treatment
of endocarditis is the lack of data on the
optimal concentrations required. Although the
correlation between very high b-lactam plasma
concentrations and toxicity (especially neurolog-
ical toxicity) is likely, it has not yet been
demonstrated formally. Likewise, even though
animal models suggest that trough plasma
b-lactam concentrations of 4· MIC are sufﬁcient,
it is not clear whether these data can be
extrapolated to humans. Although there is no
reason to increase the trough plasma b-lactam
concentrations to > 10· MIC for the treatment of
endocarditis (R. Tulkens, personal communica-
tion), the results of the present study suggest
that the use of current guidelines probably leads
to even higher concentrations in most patients,
and particularly in the elderly. The conse-
quences of these high concentrations remain to
be determined. HPLC could offer an opportun-
ity to monitor plasma b-lactam concentrations,
and would allow individualised rather than
standardised treatment. Prospective, random-
ised, multicentre studies are required to evalu-
ate the impact of such monitoring on
endocarditis therapy.
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ABSTRACT
This report describes a retrospective analysis of 33
patients admitted to an intensive care unit with
suspicion of necrotising fasciitis (NF) of the
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extremities. The aim of the study was to clarify
the clinical presentation of NF in order to
determine when early surgery should be consid-
ered. Twenty-one patients with surgically con-
ﬁrmed NF were compared to 12 patients with
superﬁcial soft tissue infection. At admission,
patients with NF were more likely to have skin
areas of ischaemia or necrosis, ﬂuid-ﬁlled vesicles,
and severe sepsis or septic shock.
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Severe skin or soft tissue (SST) infections can
involve fascia planes, thereby constituting necro-
tising fasciitis (NF). Such infections are character-
ised by extensive necrosis and systemic toxicity
[1,2]. Early clinical diagnosis of NF, and differen-
tiation between NF and superﬁcial SST infection
(erysipela or cellulitis), may be difﬁcult [3,4].
However, early surgical debridement of patients
with NF has been associated with improved
survival when compared with delayed surgical
exploration [5,6]. The present study describes a
retrospective analysis of 33 patients admitted to
an intensive care unit (ICU) with severe SST
infection of the extremities, with the aim of
clarifying the clinical presentation of NF and
determining when patients should be referred for
early surgery.
Data collected included patient demographics,
source of infection, predisposing factors, clinical
presentation, laboratory parameters, bacteriologi-
cal ﬁndings, management, duration of ICU and
hospital stay, and rate of survival. The severity of
sepsis at presentation was assessed according to
published guidelines and deﬁnitions [7], and the
severity of acute illness was assessed with the
Simpliﬁed Acute Physiology Score II (SAPS II) [8].
NF was deﬁned as a soft tissue infection with
fascia involvement conﬁrmed at surgery, while
superﬁcial SST infection (or ‘medical’ infection)
was deﬁned as either (1) soft tissue infection
without fascia involvement, as conﬁrmed by
surgical exploration, or (2) soft tissue infection
that resolved without surgery. In order to exam-
ine features associated with NF cases needing
surgical debridement, patients with medical SST
infections were compared to patients with con-
ﬁrmed NF. The data were compared by means of
the Mann–Whitney U-test.
In total, 25 (76%) patients underwent surgical
exploration. The mean delay between diagnosis
and surgery was 3.4 days (range 0–23 days); 18
patients had surgery within 48 h of diagnosis. At
surgery, NF was conﬁrmed in 21 (84%) of these
patients, while four patients were diagnosed with
superﬁcial SST infection.
Twenty-one patients were referred for primary
therapy, including 16 who failed to improve after
initial therapy. Four patients presented with
severe sepsis and 11 with septic shock. The mean
age of the patients was 59 years (range
20–88 years). A medical condition predisposing
to soft tissue infection was noted in 21 (64%)
patients, namely diabetes mellitus (n = 11), cancer
(n = 4; all receiving chemotherapy), corticosteroid
therapy (n = 8; all receiving > 1 mg ⁄ kg ⁄day pred-
nisone equivalent) and liver cirrhosis (n = 4); four
patients had received non-steroidal anti-inﬂam-
matory drugs. A precipitating factor was recorded
for 24 (73%) patients, in that 11 patients had a pre-
existing local infection and 13 patients had a recent
history of trauma. The latter group included
minor or major limb injury (n = 8), intramuscular
injections (n = 4) or surgical amputation (n = 1).
Seven cases of infection were hospital-acquired
after liposuction surgery (n = 1), bedsore infection
(n = 2), infected haematoma while receiving anti-
coagulant therapy (n = 1), leg ischaemia (n = 1) or
surgical wound infection (n = 2).
Physical ﬁndings are detailed in Table 1. NF
was associated signiﬁcantly with cyanosis, nec-
rotic skin areas, and ﬂuid-ﬁlled vesicles. The
mean SAPS II on admission was 34.5 (range 10–
96). Patients with NF presented frequently with
severe sepsis or shock (n = 15; 71%), whereas
there were no such cases among patients with
medical SST infection (p 0.0003). There was no
difference in laboratory test parameters between
the two groups (Table 1).
Microbiological ﬁndings are detailed in
Table 2. Staphylococcus and Streptococus spp. were
the most common isolates (Table 2). No microbial
pathogen was isolated from 12 patients. Microor-
ganisms were recovered more frequently from
patients with NF (86% vs. 25%; p 0.001). Blood
cultures were positive for 15 patients, of whom
ten also had positive tissue or ﬂuid culture
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results. For six patients, only tissue or ﬂuid
culture results were positive. NF was associated
more frequently with bacteraemia (57%) than was
superﬁcial SST infection (25%; p 0.009).
Empirical antibiotics were administered to all
patients, of whom nine received a single antibi-
otic, 14 received a combination of two antibiotics,
and ten received a combination of three or more
antibiotics. The antibiotics used were b-lactams
(26 patients), aminoglycosides (18), third-genera-
tion cephalosporins (seven), metronidazole (ten),
clindamycin (two), and other miscellaneous anti-
biotics (ﬁve). The overall mortality rate was 33%.
The mean length of stay in the ICU was 10.6 days
(range 1–49 days). There were no deaths in the
‘medical’ group, whereas 52% of patients with
NF died (Table 1).
Controversies persist over the classiﬁcation of
severe SST infections [9,10]. However, a prag-
matic clinical–anatomical classiﬁcation [3] is used
most commonly, based on the different anatom-
ical planes involved and the causative disease. On
comparison of patients with NF conﬁrmed at
surgery to those who progressed favourably with
medical therapy only, it was found that the
former were much more likely to have severe
sepsis or shock. None of the patients with medical
severe SST infection presented with shock,
despite a similar SAPS II assessment (Table 2).
Therefore, the results suggest that patients pre-
senting with septic shock should undergo rapid
surgical exploration, together with resuscitation.
Indeed, systemic symptoms are an indication that
a necrotising infection has already spread across a
large surface area and has disseminated toxins
[11,12]. The present study also conﬁrmed previ-
ous observations [13–15] that patients with NF
present more frequently with cyanosis, skin
necrosis and ﬂuid-ﬁlled vesicles. However, the
speciﬁcity of these ﬁndings was not 100%, and a
few patients with severe medical SST infection
presented with such signs (Table 2).
Microbiological ﬁndings also differed between
patients with NF and those with medical SST.
Bacteraemia was much more common in patients
with NF (57% vs. 25%), often in association with
severe sepsis and septic shock. Polymicrobial
infection was recorded rarely in this series of
patients, which included only SST infection of the
extremities, and was not more frequent in patients
with NF. Indeed, severe SST infection of the limbs
is more often monomicrobial, with the involve-
ment of skin ﬂora [16].
NF is a rare but serious bacterial disease that is
often underestimated and poorly recognised [17].
Of the 21 cases in this study, only nine were
suspected by the referring or admitting physician,
and diagnosis was delayed by 2–10 days follow-
ing the onset of symptoms. A high index of
suspicion is mandatory for an early diagnosis,
Table 1. Clinical characteristics of 33 patients with necro-







n = 12 p
Age, years (mean) 58.8 ± 16.9 61.5 ± 15.4 54.6 ± 19.1 0.4
Temperature (mean) 38.1 ± 1.2 38.2 ± 1.3 37.8 ± 1.3 0.42
SAPS II (mean) 36.5 ± 22 36.9 ± 21 31.2 ± 16 0.5
DIC (no. of patients) 6 5 1 0.3
Clinical presentation
Crepitus 9 7 2 0.5
Necrosis 18 16 2 0.003
Ischaemia 11 10 1 0.1
Cyanosis 14 12 2 0.02
Fluid-ﬁlled vesicles 16 14 2 0.01
Pain 27 17 10 0.6
Erythema 26 17 9 0.6
Immunodepression 21 14 7 0.4
Biological ﬁndings
Leukocyte count 12.5 ± 7.9 12.9 ± 7.7 11.9 ± 8.5 0.7
Fibrin 6.4 ± 3 5.5 ± 2.7 6.7 ± 3.1 0.3
CPK 2008 ± 5241 2819 ± 6243 304.5 ± 439.6 0.2
C-reactive protein 252 ± 147 291 ± 101 240 ± 161 0.6
Platelets 226 ± 160 203 ± 154 238 ± 165 0.6
Severe sepsis or shock
at admission
(no. of patients)
15 15 0 < 0.001
Mechanical ventilation 18 16 2 0.003
Renal replacement
therapy
7 7 0 0.03
Vasopressive drugs 12 11 1 0.02
Adequate antibiotic
therapy within 48 h
30 19 11 1
Survivors 11 12 0.005
CPK, creatine phosphokinase; DIC, disseminated intravascular coagulation; SAPS
II, Simpliﬁed Acute Physiology Score II; SST, skin or soft tissue.








Organism(s) isolated 3 18
Bacteraemia 3 12
Monomicrobial ⁄polymicrobial 3 ⁄ 0 15 ⁄ 3
Gram-negative bacilli 0 8
Gram-positive cocci 3 12
Gram-negative bacilli 8
Escherichia coli 2 2
Klebsiella pneumoniae 2 2
Citrobacter freundii 1 1
Pseudomonas aeruginosa 1 1
Proteus mirabilis 1 1
Morganellla morganii 1 1
Gram-positive cocci 15
Staphylococcus aureus 2 7 9
Streptococcus pyogenes 0 3 3
Streptococcus spp. 1 2 3
NF, necrotising fasciitis; SST, skin or soft tissue.
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since early and adequate surgical debridement
and fasciotomy has been associated with im-
proved survival compared to delayed surgical
intervention [13,18].
The present study had several limitations,
including its retrospective design and the small
number of patients; however, it was possible to
identify four clinical factors and one microbiolo-
gical factor that were associated signiﬁcantly with
NF in patients admitted to an ICU with severe
SST infection. The presence of these signs should
prompt early surgical exploration.
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